Regional campaigns: Improving local uptake while staying on-message

Dolan Desai|22nd October 2015




At Blue Latitude Health, our strategic planning, customer experience, and creative services teams work together to ensure that our clients’ campaigns launch without a hitch. We work across many different therapy areas, helping brands to position, launch, and support their campaigns at global, regional, and local levels. Localising global and regional campaigns is a challenge all global organisations face. However, for healthcare brands, it can be even more challenging because local regulations and healthcare systems can be so wildly variable and complicated.

A lot of work goes into a regional marketing strategy, but without coherent execution at the local level, the campaign loses impact. Account Director Dolan Desai talks us through the five core considerations that will allow you to maximise impact across a region through coherent execution:

1.  First and foremost, pin down your messaging

Before worrying about country-level assets, you must be crystal clear on what you want those assets to say. Not taking the time to establish and support the regional messaging before rolling out locally can lead to unfocussed and disjointed local activity. Once your messaging is clear, meaning you know what you want to say, and to whom, then you’re ready to move on to the next step: the messaging framework.  

 

How Medisafe is using AI to improve patient adherence

Dina Patel|14th February 2019

Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence.

read more

Downloadable Pack: Understanding Multiple Sclerosis

Blue Latitude Health, Guest Blogger|6th February 2019

Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry.

read more

Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy

Guest Blogger|1st February 2019

MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget.

read more